ES2206438T3 - Derivados de isoindolo-indolona, su procedimiento de preparaacion y las composiciones farmaceuticas que los contienen. - Google Patents

Derivados de isoindolo-indolona, su procedimiento de preparaacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
ES2206438T3
ES2206438T3 ES02290598T ES02290598T ES2206438T3 ES 2206438 T3 ES2206438 T3 ES 2206438T3 ES 02290598 T ES02290598 T ES 02290598T ES 02290598 T ES02290598 T ES 02290598T ES 2206438 T3 ES2206438 T3 ES 2206438T3
Authority
ES
Spain
Prior art keywords
branched
linear
formula
compound
oxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02290598T
Other languages
English (en)
Spanish (es)
Inventor
Michel Wierzbicki
Marie-Francoise Boussard
Anne Rousseau
Jean-Albert Boutin
Philippe Delagrange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Application granted granted Critical
Publication of ES2206438T3 publication Critical patent/ES2206438T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES02290598T 2001-03-12 2002-03-11 Derivados de isoindolo-indolona, su procedimiento de preparaacion y las composiciones farmaceuticas que los contienen. Expired - Lifetime ES2206438T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0103293 2001-03-12
FR0103293A FR2821843B1 (fr) 2001-03-12 2001-03-12 Nouveaux derives d'isoindoloindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ES2206438T3 true ES2206438T3 (es) 2004-05-16

Family

ID=8860976

Family Applications (1)

Application Number Title Priority Date Filing Date
ES02290598T Expired - Lifetime ES2206438T3 (es) 2001-03-12 2002-03-11 Derivados de isoindolo-indolona, su procedimiento de preparaacion y las composiciones farmaceuticas que los contienen.

Country Status (24)

Country Link
US (1) US6465660B1 (show.php)
EP (1) EP1241169B1 (show.php)
JP (1) JP3842151B2 (show.php)
KR (1) KR100450313B1 (show.php)
CN (1) CN1159316C (show.php)
AR (1) AR034583A1 (show.php)
AT (1) ATE248171T1 (show.php)
AU (1) AU779702B2 (show.php)
BR (1) BR0200721A (show.php)
CA (1) CA2376876C (show.php)
DE (1) DE60200023T2 (show.php)
DK (1) DK1241169T3 (show.php)
EA (1) EA004035B1 (show.php)
ES (1) ES2206438T3 (show.php)
FR (1) FR2821843B1 (show.php)
HK (1) HK1049000B (show.php)
HU (1) HUP0200913A3 (show.php)
MX (1) MXPA02002601A (show.php)
NO (1) NO20021198L (show.php)
NZ (1) NZ517742A (show.php)
PL (1) PL352750A1 (show.php)
PT (1) PT1241169E (show.php)
SI (1) SI1241169T1 (show.php)
ZA (1) ZA200202030B (show.php)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2826009B1 (fr) * 2001-06-13 2003-08-15 Servier Lab Nouveaux derives d'indenoindolones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PT1517909E (pt) * 2002-06-21 2007-01-31 Suven Life Sciences Ltd Novos arilcarbonilindoles tetracíclicos que possuem afinidade para o receptor de serotonina, úteis como agentes terapêuticos, processo para a sua preparação e composições farmacêuticas que os contêm
CA2490115C (en) * 2002-06-21 2009-09-01 Suven Life Sciences Limited Arylalkyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
EP1567492B1 (en) * 2002-11-28 2013-05-22 Suven Life Sciences Limited N-arylsulfonyl-3-aminoalkoxyindoles
KR100739987B1 (ko) * 2002-12-18 2007-07-16 수벤 라이프 사이언시스 리미티드 세로토닌 수용체 친화력을 가지는 테트라사이클릭 3-치환인돌
RU2387655C2 (ru) * 2004-08-09 2010-04-27 Бристол-Маерс Сквибб Компани Ингибиторы репликации вируса гепатита с
ES2580702B1 (es) 2015-02-25 2017-06-08 Palobiofarma, S.L. Derivados de 2-aminopiridina como antagonistas del receptor A2b de adenosina y ligandos del receptor MT3 de melatonina
US20240090802A1 (en) 2022-09-02 2024-03-21 Dexcom, Inc. Continuous analyte sensor devices and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5377098A (en) * 1976-12-16 1978-07-08 Sumitomo Chem Co Ltd Preparation of indoloisoquinoline derivative
US4452808A (en) * 1982-12-07 1984-06-05 Smithkline Beckman Corporation 4-Aminoalkyl-2(3H)-indolones
US5441955A (en) * 1993-11-19 1995-08-15 Pathogenesis Corporation Indolo[2,1-biquinazoline-6,12-dione antibacterial compounds and methods of use thereof
FR2743365A1 (fr) * 1996-01-10 1997-07-11 Rhone Poulenc Rorer Sa Derives de 5h,10h-imidazo(1,2-a)indolo(3,2-e)pyrazine-4-one, leur preparation et les medicaments les contenant
WO2002000215A1 (en) * 2000-06-23 2002-01-03 Cognetix, Inc. Subtype selective melatonergics

Also Published As

Publication number Publication date
CN1159316C (zh) 2004-07-28
JP3842151B2 (ja) 2006-11-08
AU779702B2 (en) 2005-02-10
DK1241169T3 (da) 2003-11-24
ZA200202030B (en) 2002-10-03
NO20021198D0 (no) 2002-03-11
HUP0200913A2 (hu) 2002-11-28
DE60200023T2 (de) 2004-06-03
DE60200023D1 (de) 2003-10-02
FR2821843B1 (fr) 2003-05-09
AR034583A1 (es) 2004-03-03
ATE248171T1 (de) 2003-09-15
JP2002265469A (ja) 2002-09-18
AU2324202A (en) 2002-09-19
HUP0200913A3 (en) 2004-11-29
HK1049000B (zh) 2005-01-07
NZ517742A (en) 2003-02-28
CA2376876A1 (fr) 2002-09-12
CA2376876C (fr) 2006-07-11
KR20020072782A (ko) 2002-09-18
CN1375494A (zh) 2002-10-23
EP1241169A1 (fr) 2002-09-18
NO20021198L (no) 2002-09-13
MXPA02002601A (es) 2004-11-12
PT1241169E (pt) 2003-11-28
PL352750A1 (en) 2002-09-23
HU0200913D0 (show.php) 2002-05-29
US6465660B1 (en) 2002-10-15
KR100450313B1 (ko) 2004-09-30
BR0200721A (pt) 2002-12-03
FR2821843A1 (fr) 2002-09-13
EA004035B1 (ru) 2003-12-25
SI1241169T1 (en) 2003-12-31
HK1049000A1 (en) 2003-04-25
EA200200241A1 (ru) 2002-10-31
EP1241169B1 (fr) 2003-08-27

Similar Documents

Publication Publication Date Title
JPH05505599A (ja) 治療上有用な複素環インドール化合物類
JPH10101591A (ja) ウイルス感染症の予防・治療剤
EP0492485A1 (en) N-Acyl-2,3-benzodiazepine derivatives, pharmaceutical compositions containing them and process for preparing same
CN107530350A (zh) 细胞坏死抑制剂及相关方法
AU2020200846A1 (en) Piperidine derivatives as hdac1/2 inhibitors
ES2261978T3 (es) Compuestos piridopirimidinona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
CN101970436A (zh) 用于治疗中枢神经系统功能障碍的氮杂吲哚化合物
ES2206438T3 (es) Derivados de isoindolo-indolona, su procedimiento de preparaacion y las composiciones farmaceuticas que los contienen.
WO2011036885A1 (ja) 複素環化合物
ES2207629T3 (es) Derivados de indeno-indolonas, su procedimiento de preparacion y las composiciones farmaceuticos que los contienen.
ES2285775T3 (es) Compuestos heterociclicos sustituidos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
Toja et al. 1-Alkyl-1, 2, 5, 6-tetrahydropyridine-3-carboxaldehyde-O-alkyl-oximes: A new class of potent orally active muscarinic agonists related to arecoline
IE903122A1 (en) Benzazabicyclic carbamates as novel cholinesterase¹inhibitors
AU722147B2 (en) N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics
ES2301979T3 (es) Derivados de 4-(2-fenilsulfanil-fenil)-1,2,3,6-tetrahidropiridina como inhibidores de la reabsorcion de serotonina.
CN1900075A (zh) 一类四氢原小檗碱类化合物、其制备方法及其组合物和用途
ES2295794T3 (es) Nuevos derivados de isoquinoleina, su procedimiento de preparacion y su utilizacion para tratar trastornos del sistema melatoninergico.
PL195667B1 (pl) Nowe związki cykliczne zawierające łańcuch cyklopropylenowy, sposób ich wytwarzania, kompozycje farmaceutyczne zawierające te związki i ich zastosowanie
MX2007007900A (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
Press et al. Thiophene systems. 4. Selective syntheses of thieno [3, 4‐b][1, 4]‐and [1, 5] benzodiazepinones
TWI457341B (zh) 胺基亞丙基衍生物
CN118290330A (zh) 一种酰胺衍生物及其在医药上的应用
JPS6183171A (ja) ジベンゾ〔ｂ，ｆ〕〔１，５〕オキサゾシン誘導体及びその製造法並びにそれを有効成分とする医薬
JPH10218864A (ja) ジヒドロフェナジンカルボン酸誘導体
PT100191B (pt) Derivados n-acil-2,3-benzodiazepinicos, composicoes farmaceuticas que os contem e processos para a preparacao dos derivados e da composicao, metodo de bloqueioe metodo de tratamento